IntercontinentalExchange/NY Board › U.S $ INDEX (NYBOT:DX)
89.238 +0.163 (+0.21%)
2014-12-18 14:51:30, 30 min delay
|52wk High Date||2014-12-08|
|52wk Low Date||2014-05-08|
Today's Top 50 Trending Stocks: Let our SmartScan and Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly rank today's top 50 stocks for you. This complimentary list will update throughout the day to highlight the most timely trading opportunities.
Has The Market Made A U-Turn?
37 minutes ago
Joel Horneck And Fed Policy
2 hours, 7 minutes ago
For Traders and Asset Managers, Puerto Rico's Tax Incentives Are a No-Brainer
5 hours ago
Today's Financial News
2 hours, 43 minutes ago
BUTTE, Mont. (AP) — One-time billionaire Tim Blixseth is due in federal court Thursday to explain why he failed to comply with an order to pay $13.8 million to the creditors of an ultra-luxury Montana resort. Blixseth delayed potential court sanctions for months with an unsuccessful appeal to the 9th Circuit U.S. Court of Appeals.
2 hours, 45 minutes ago
BRUSSELS (AP) — European Union leaders met Thursday to seek solutions to two major challenges — how to jumpstart sluggish economic growth at home, and how to deal long-term with Russia. The fund is supposed to leverage EU seed money and loan guarantees into up to 315 billion euros ($386 billion) of private-sector investment to upgrade infrastructure, create jobs and stimulate growth.
2 hours, 47 minutes ago
ABU DHABI, United Arab Emirates (AP) — Abu Dhabi's national carrier, Etihad, has showcased the arrival of its first Airbus A380, outfitted with "the only three-room suite in the sky." The fast-growing Gulf carrier also showcased Thursday its first Boeing 787 Dreamliner, which will begin flying to Dusseldorf, Germany, on Feb. 1.
2 hours, 49 minutes ago
KENILWORTH, N.J. (AP) — Drugmaker Merck says it's bought a Swiss biotech company developing cancer drugs as part of its strategy to be a top player in cancer, one of the hottest pharmaceutical research areas. The deal gives Merck ownership of an experimental treatment called OTX015 that could be the first in a new class of drugs that block proteins involved in cancer cell growth and survival.